Month: January 2021
-
Reward processing in major depressive disorder and prediction of treatment response – Neuropharm study
Eur Neuropsychopharmacol. 2021 Mar;44:23-33. doi: 10.1016/j.euroneuro.2020.12.010. Epub 2021 Jan 15. ABSTRACT Major depressive disorder (MDD) is a prevalent brain disorder for which anhedonia is a core symptom, indicating aberrations in the neural processing of reward. The striatum, medial prefrontal cortex (mPFC) and anterior insula (AI) are core reward processing regions. Here we used a reward-related, […]
-
Reward processing in major depressive disorder and prediction of treatment response – Neuropharm study.
Related Articles Reward processing in major depressive disorder and prediction of treatment response – Neuropharm study. Eur Neuropsychopharmacol. 2021 Jan 14;: Authors: Brandt IM, Köhler-Forsberg K, Ganz M, Ozenne B, Jorgensen MB, Poulsen A, Knudsen GM, Frokjaer VG, Fisher PM Abstract Major depressive disorder (MDD) is a prevalent brain disorder for which anhedonia is a […]